ArticleNature medicine2021
Prisons as ecological drivers of fitness-compensated multidrug-resistant Mycobacterium tuberculosis.
Erratum issuedOpen access · greenAbstract read
In one paragraph
Article in Nature medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 46 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
46 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.
- Beyond Prison Walls: A Scoping Review of Incarceration's Public Health Impacts in Latin America.Wellcome open research · 2026Pooled it
- Estimating the contribution to transmission of asymptomatic tuberculosis from population-based genomic epidemiology studies.Emerging microbes & infections · 2026Article
- Limited contribution of compensatory mutations to MDR/RR-TB clustering in Hunan Province, China: a population-based whole-genome sequencing study.Microbiology spectrum · 2026Article
- The global phylogeography of rapidly expanding multidrug resistant Ural lineage 4.2 Mycobacterium tuberculosis.Nature communications · 2026Article
- Drug-Resistant Tuberculosis in Prisons of Latin America and the Caribbean: A Critical Reflection on Structural Challenges and Gaps.Tropical medicine and infectious disease · 2026Review
- Within-host evolution of drug tolerance inJAC-antimicrobial resistance · 2026Article
- Copper Single-Atoms Loaded on Molybdenum Disulphide Drive Bacterial Cuproptosis-Like Death and Interrupt Drug-Resistance Compensation Pathways.Nano-micro letters · 2026Article
- Variability in intrinsic drug tolerance inAntimicrobial agents and chemotherapy · 2025Article
- Ecology, global diversity and evolutionary mechanisms in the Mycobacterium tuberculosis complex.Nature reviews. Microbiology · 2025Review
- Gene conversion and duplication contribute to genetic variation in an outbreak ofMicrobial genomics · 2025Article
- Global perspectives on tuberculosis in prisons and incarceration centers - Risk factors, priority needs, challenges for control and the way forward.IJID regions · 2025Review
- Transmission ofEpidemiology and infection · 2025Article
- Transmission as a Key Driver of Resistance to the New Tuberculosis Drugs.The New England journal of medicine · 2025Article
- Linking genetic and phenotypic bedaquiline resistance in Mycobacterium tuberculosis strains from Georgia.PloS one · 2025Article
- Signatures of transmission in within-host Mycobacterium tuberculosis complex variation: a retrospective genomic epidemiology study.The Lancet. Microbe · 2025Article
- Transmission of tuberculosis in rural Henan, China: a prospective population-based genomic spatial epidemiological study.Emerging microbes & infections · 2024Article
- Mass incarceration as a driver of the tuberculosis epidemic in Latin America and projected effects of policy alternatives: a mathematical modelling study.The Lancet. Public health · 2024Article
- Differential rates of Mycobacterium tuberculosis transmission associate with host-pathogen sympatry.Nature microbiology · 2024Article
- Mass incarceration as a driver of the tuberculosis epidemic in Latin America and projected impacts of policy alternatives: A mathematical modeling study.medRxiv : the preprint server for health sciences · 2024Article
- Large-scale statistical analysis of Mycobacterium tuberculosis genome sequences identifies compensatory mutations associated with multi-drug resistance.Scientific reports · 2024Article
Corrections and comments
- Erratum issued
Authors and funding
15 authors at 3 institutions in 2 countries.
Sebastian M Gygli *Swiss Tropical and Public Health Institute, Basel, Switzerland.
Chloé Loiseau *Swiss Tropical and Public Health Institute, Basel, Switzerland.
Levan JugheliSwiss Tropical and Public Health Institute, Basel, Switzerland.
Natia AdamiaNational Center for Tuberculosis and Lung Diseases (NCTLD), Tbilisi, Georgia.
Andrej TraunerSwiss Tropical and Public Health Institute, Basel, Switzerland.ORCID http://orcid.org/0000-0002-6260-9829
Miriam ReinhardSwiss Tropical and Public Health Institute, Basel, Switzerland.
Amanda RossSwiss Tropical and Public Health Institute, Basel, Switzerland.ORCID http://orcid.org/0000-0001-6027-5645
Sonia BorrellSwiss Tropical and Public Health Institute, Basel, Switzerland.
Rusudan AspindzelashviliNational Center for Tuberculosis and Lung Diseases (NCTLD), Tbilisi, Georgia.
Nino MaghradzeSwiss Tropical and Public Health Institute, Basel, Switzerland.
Klaus ReitherSwiss Tropical and Public Health Institute, Basel, Switzerland.
Christian BeiselDepartment of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.ORCID http://orcid.org/0000-0001-5360-2193
Nestani TukvadzeSwiss Tropical and Public Health Institute, Basel, Switzerland.
Zaza AvalianiNational Center for Tuberculosis and Lung Diseases (NCTLD), Tbilisi, Georgia.
Sebastien GagneuxSwiss Tropical and Public Health Institute, Basel, Switzerland. sebastien.gagneux@swisstph.ch.ORCID http://orcid.org/0000-0001-7783-9048
Swiss Tropical and Public Health Institute · CHNational Center for Tuberculosis and Lung Disease · GEETH Zurich · CH
Funding
Emory-Georgia TB Research Training ProgramD43TW007124 · FIC · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Nestani Tukvadze · 2004 to 2026
$4.6MEC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 309540-EVODRTBEC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 883582-ECOEVODRTBFIC NIH HHS D43 TW007124Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 310030_188888Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) CRSII5_177163Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) IZLSZ3_170834Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) IZRJZ3_164171
Abstract
Multidrug-resistant tuberculosis (MDR-TB) accounts for one third of the annual deaths due to antimicrobial resistance
Indexed as
PrisonsAntitubercular AgentsDrug Resistance, Multiple, BacterialHumansMutationMycobacterium tuberculosisPrisonersTuberculosis, Multidrug-ResistantAntitubercular Agents
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.